COSTA MESA, Calif. – Gold Flora Corporation, a leading vertically-integrated California cannabis company, announced its  financial results for the three-month period (“Q4 2023”) and twelve-month period (“FY 2023”) ended December 31, 2023. All amounts are expressed in U.S. dollars.

Q4 and FY 2023 Financial Highlights

• Total revenue was $28.4 million for Q4 2023 and $91.0 million for FY 2023.
• Q4 2023 gross profit of $13.2 million, representing a 46% gross margin. FY 2023 gross profit was $32.5 million, representing a 36% gross margin.
• Q4 2023 adjusted gross profit[1] of $18.7 million, representing a 66% adjusted gross margin. FY 2023 adjusted gross profit was $48.0 million, representing a 53% adjusted gross margin. Adjusted gross profit excludes operating expenses (including depreciation and amortization) related to U.S. tax code 280E adjustments, and non-recurring inventory adjustments.
• Net loss of $(42.2) million for Q4 2023 and $(42.7) million for FY 2023.
• Adjusted EBITDA of $0.11 million for Q4 2023 and negative $(1.4) million for FY 2023.
• Cash and cash equivalents totaled $22.5 million as of December 31, 2023.

Q4 2023 Operational Highlights

Following a strategic review of its operations in connection with the Company’s focus on long-term, high-margin revenue sources, Gold Flora elected to close select, non-profitable delivery depot locations and sold one of its underperforming retail licenses. These decisions resulted in a short-term negative impact on topline revenue in Q4 2023, however they have had an immediate positive impact on the Company’s long-term profitability goals.

Successfully completed the business combination and integration of legacy operations. The resulting combined Company is strongly positioned in the California market and has identified and realized significant synergies of approximately $30 million in annualized cost savings.

Invested in restarting cultivation at Caliva and Airfield Supply Company, both in San Jose, expanding the Company’s active cultivation canopy to approximately 107,000 square feet. Revenue from the newly reactivated facilities will contribute to the Company’s first quarter of 2024, as the first harvests from the fully planted facilities were mostly occurred subsequent to the quarter and fiscal year end.

Developed a new, disruptive product brand, Gramlin. Designed to appeal to high-volume consumers that frequently purchase flower, vape and pre-roll products, Gramlin successfully launched in March 2024 through the Company’s first party retail outlets and Stately Distribution across California. Gramlin features new genetic strains grown at Gold Flora’s newly online cultivation rooms and is strategically priced to offer an unmatchable quality to price ratio leveraging the Company’s vertical footprint.

Management Commentary

“We have strategically built a solid foundation consisting of premier indoor cultivation, and full vertical operations with deep consumer insights that has enabled our business to continue to expand its leadership position in California,” said Laurie Holcomb, Chief Executive Officer of Gold Flora. “This platform, combined with our focus on high-quality, profitable revenue streams has allowed us to capture more margin across every step of the supply chain and, as a result, we achieved positive adjusted EBITDA in the quarter, and improved our adjusted gross margin to approximately 66%, ahead of some of the leading multi-state operators in the industry. Where other operators have experienced persistent challenges in California, our purpose-built and difficult to replicate footprint allows us to succeed and grow scale consistently.”

Ms. Holcomb continued, “Our success in California and ability to maintain and grow our market share, despite overall declines in the market, is a testament to our strong customer loyalty supported by our consistent delivery of top-quality products. This has also resulted in a significantly higher quality of revenue, providing stability as well as supporting our long-term profitability plans. The majority of our revenue now comes directly from our owned brands and augmented by our retail store network, which is based in highly desirable, limited license locations.”

Ms. Holcomb concluded, “The work we undertook and investments we have made in 2023 were crucial to ensure we began 2024 ready to capitalize on the substantial untapped opportunity here in California and achieve our goal of generating positive cash flow this year. Gold Flora was designed to lead the market, and the results we are seeing and the consumer feedback we have received tell us we are not only meeting but exceeding our clients’ expectations. We’re in the right place at the right time; we worked hard to get here, and we are prepared and eager for what comes next.”

The Company’s consolidated financial statements, as well as its accompanying management discussion and analysis of financial condition and results of operations (“MD&A”) will be included in its Annual Report on Form 10-K filed on EDGAR (www.sec.gov) as well as SEDAR (www.sedar.com). Please refer to Gold Flora Corporation’s MD&A for additional detail and discussion on the Company’s results from operations.

About Gold Flora Corporation

Gold Flora Corporation is a female-led, vertically-integrated cannabis leader that owns and operates a robust portfolio of 10 cannabis brands, which are sold through its 16 retail dispensaries and, through its Stately Distribution business, to retailers throughout California. Its retail operations include Airfield Supply Company, Caliva, Coastal, Calma, King’s Crew, Varda, Deli, and Higher Level .

Gold Flora Corporation operates an indoor cultivation canopy of approximately 107,000 square feet across three facilities in its Desert Hot Springs campus and two San Jose cultivation facilities. The Company can expand further, adding approximately 240,000 square feet of canopy on already entitled additional acreage. Importantly this opportunity is unique and can be timed to meet market demand. The Desert Hot Springs campus also houses the Company’s manufacturing and extraction facilities, as well as Stately Distribution. The centralized location provides for optimal security and logistic benefits and protects the product as it moves though the Company’s overall pipeline.

With hubs throughout the state, the Company distributes many prominent brands, including its own premium lines of Gold Flora, Gramlin, Cruisers, CURRENT, Roll Bleezy, Sword & Stoned, Aviation Cannabis, Jetfuel Cannabis, Caliva, Mirayo by Santana, and Monogram. Third party brands are increasingly contacting the Company in search of reliable input sources and established distribution.

References to information included on, or accessible through, websites and social media platforms do not constitute incorporation herein by reference of the information contained at or available through such websites or social media platforms, and the reader should not consider such information to be part of this press release.

For the latest news, activities, and media coverage, please visit www.goldflora.com.

Non-GAAP Financial Measures

This news release contains the non-GAAP financial measure “Adjusted EBITDA,” and “Adjusted Gross Profit” which are not recognized under GAAP and do not have a standardized meaning prescribed by GAAP. As a result, these measures may not be comparable to similar measures presented by other companies.

Adjusted EBITDA

We believe Adjusted EBITDA is a useful measure to assess the performance of the Company as it provides more meaningful operating results by excluding the effects of expenses that are not reflective of our underlying business performance and other one-time or non-recurring expenses. We define “Adjusted EBITDA” as EBITDA adjusted to exclude extraordinary items, non-recurring items and, other non-cash items, including, but not limited to (i) stock-based compensation expense, (ii) change in fair value of the earn out liability,  (iii) non-recurring legal and professional fees, human-resources, inventory and collections-related expenses, (iv) intangible and goodwill impairments and loss on disposal of assets, (v) transaction costs related to merger and acquisition activities, (vi) retail and cultivation pre-opening costs, and (vii) non-recurring inventory adjustments.

Adjusted Gross Profit

We believe Adjusted Gross Profit is a useful measure to assess the performance of the Company as it provides more meaningful operating results by excluding the effects of expenses that are not reflective of our underlying business performance.  We define “Adjusted Gross Profit” as Gross Profit adjusted to exclude operating expenses (including depreciation and amortization) related to U.S. tax code 280E adjustments and non-recurring inventory adjustments.

Forward Looking Statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to the expectations or forecasts of business, operations, financial performance, prospects, and other plans, intentions, estimates and beliefs, and may include statements regarding Gold Flora’s expected financial condition and performance, the current and projected market, and growth opportunities for the company. Words such as “expects,” “continue,” “will,” “anticipates,” and “intends,” or similar expressions, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements in this press release include, but are not limited to, statements relating to the Company’s estimated financial results for Q4 2023 and FY2023, the impact of divestitures on long-term profitability goals, the ability to realize synergies following the business combination, the timing of revenue from reactivated facilities, and the Company’s ability to generate positive cash flow during 2024. These forward–looking statements are based on Gold Flora’s current projections and expectations about future events and financial trends that it believes might affect its financial condition, results of operations, prospects, business strategy and financial needs, and on certain assumptions and analysis made by it in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements to be materially different from future events, results, performance, and achievements expressed or implied by forward looking information and statements herein. Although Gold Flora believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, Gold Flora does not assume any obligation to update or revise any forward-looking information or statements contained herein or to update the reasons that actual events or results could or do differ from those projected in any forward-looking information and statements herein, whether as a result of new information, future events or results, or otherwise.

• SEO Powered Content & PR Distribution. Get Amplified Today.
• PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
• PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
• PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
• PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
• Source: https://mgmagazine.com/press-releases/gold-flora-reports-fourth-quarter-and-full-year-2023-financial-results/